Viewing nowAtorvastatin Calcium Trihydrate 40mg Tablet
Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

MFDS item code 200808796 · Notified 2008.08.19 · Insurance code 642705320
Improvement of dyslipidemia and prevention of cardiovascular disease (including myocardial infarction and stroke)
This medication helps to reduce the risks of cardiovascular diseases. It decreases the risks of various cardiovascular issues such as myocardial infarction, stroke, vascular revascularization, and chronic stable angina. It is particularly effective for patients with risk factors such as hypertension, smoking, and diabetes, and can also lower the risk of hospitalization due to congestive heart failure. Additionally, this drug is used to treat hyperlipidemia by lowering total cholesterol, LDL cholesterol, and triglyceride levels, while increasing HDL cholesterol levels. It is also used as an adjunct to diet in patients with primary dyslipidemia and familial hypercholesterolemia. Therefore, this medication is used for the prevention of cardiovascular diseases and the improvement of hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. The medication may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (the 40 mg dose is for patients requiring an LDL cholesterol reduction of 45% or more). This medication is administered once daily in a dose range of 10–80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, considering treatment goals and response. Lipid levels should be analyzed within 2–4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia This medication is administered at a dose of 10–80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.
This medication may cause abnormal symptoms in the muscles, so if you experience severe muscle pain or weakness, you should stop treatment immediately and consult a doctor. In particular, if there is a significant increase in muscle enzyme levels or if rhabdomyolysis is suspected, treatment must be discontinued. Patients with poor liver function or active liver disease should not take this medication, and regular liver function tests should be conducted when liver function abnormalities are suspected. Women who are pregnant or may become pregnant, and women who are breastfeeding should not take this medication, and fertile women should use appropriate contraception. Children under 10 years old or patients with muscle disorders should also not take this medication. Patients with a history of alcohol abuse or liver disease should consult a doctor before use and proceed with caution. Moreover, patients with impaired kidney function are at risk of myopathy so caution is necessary. This medication may have altered blood concentrations when taken with certain drugs, so if you are taking other medications, you must inform your doctor or pharmacist. If symptoms such as muscle pain, weakness, fatigue, fever, etc. occur during treatment, notify medical personnel immediately and get checked. Keep this medication out of reach of children and store in its original container to prevent misuse or degradation of quality.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture, and keep it at room temperature away from direct sunlight. By maintaining appropriate temperature and environment, the effectiveness and safety of the medication can be preserved.
White round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.